Your session is about to expire
← Back to Search
Behavioral Intervention
Mobile App for Hot Flashes
N/A
Recruiting
Research Sponsored by Baylor University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Ability to speak and understand English. Non-English speakers are not considered in this study because the Apps are currently only offered in English
Self-reported history of a minimum of 36 hot flashes per week at baseline
Must not have
Current use of hypnosis for any condition
Timeline
Screening 3 weeks
Treatment Varies
Follow Up end of treatment (week 6)
Summary
This trial aims to compare two mobile apps that help reduce hot flashes and related symptoms. Participants will use one of the apps daily for five weeks and share their feedback and experience with the app.
Who is the study for?
This trial is for individuals experiencing hot flashes and sleep disturbances, possibly related to nocturnal eating-drinking syndrome or parasomnia. Participants must be willing to use a mobile health app daily for five weeks and provide feedback on their experience.
What is being tested?
The study is testing the effectiveness of two mobile apps designed to help reduce hot flashes and improve sleep. One app uses structured attention techniques while the other employs hypnosis. The trial will compare outcomes from using these apps over a period of five weeks.
What are the potential side effects?
Since this trial involves non-invasive interventions through mobile apps, significant side effects are not anticipated. However, participants may experience varying levels of engagement or satisfaction with the app's interface or content.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I can speak and understand English.
Select...
I experience at least 36 hot flashes a week.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I am currently using hypnosis for treatment.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ end of treatment (week 6)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~end of treatment (week 6)
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Hot Flash Daily Diaries
Secondary study objectives
Adherence
App satisfaction and program ratings
Elkins Hypnotizability Scale-Clinical Form
+6 moreSide effects data
From 2020 Phase 4 trial • 133 Patients • NCT030755016%
Dry mouth
2%
Shakiness/Trembling
2%
Heart racing
1%
High heart rate and blood pressure
100%
80%
60%
40%
20%
0%
Study treatment Arm
20mg Methamphetamine
0mg Methamphetamine (Placebo)
Trial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Hypnotherapy App - EviaExperimental Treatment1 Intervention
The Evia app (https://www.eviamenopause.com/), developed by Mindset Health, provides hypnotherapy and educational resources tailored for managing hot flashes. The Evia app offers a structured 5-week program adapted from a hypnosis protocol that has been tested in various randomized clinical trials (Elkins et al., 2008; Elkins et al., 2013). During the 5-week program, users engage in daily activities such as reading brief educational materials, undergoing hypnotic sessions, and tracking their hot flashes. The app also offers users with optional hypnotherapy to improve sleep quality. The Evia app uses audio recordings to deliver hypnotherapy remotely, these are composed of mental imagery techniques focused on sensations of coolness, such as imagining cool breezes, snow, and a sense of calmness.
Group II: Health-tracker app - Talli CarePlacebo Group1 Intervention
For the health tracker app, participants will access the Talli Care app (https://talli.me/talli-care-app). The Talli Care app is a free-of-charge mobile-health application designed by Baby Logger, LLC that provides users with an interface that facilitates tracking of symptoms, physical activity, medications, water intake, and more. With the Talli Care app, participants can track their number of hot flashes, sleep quality, and additional symptoms and habits related to the management of hot flashes. Instructions regarding suggestions on what to track and how to maximize app usage will be provided to the participants by our research coordinator.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Hypnosis
2006
Completed Phase 4
~1300
Find a Location
Who is running the clinical trial?
Baylor UniversityLead Sponsor
62 Previous Clinical Trials
65,970 Total Patients Enrolled
2 Trials studying Hot Flashes
434 Patients Enrolled for Hot Flashes